Eyevance Collection (1 videos)

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Alleviate with ZERVIATETM - First New Molecule in Over 10 Years!

Channels: General, Optometry

John D. Sheppard, MD discusses ZERVIATE™ — the first topical ocular formulation of cetirizine 0.24%, an antihistamine, for the treatment of ocular itching associated with allergic conjunctivitis. This webcast archive includes audience Q&A and an overview of Eyevance's copay card program, presented by Brent Jones, Vice President of Sales, Eyevance.

Visit Us Online

INDICATIONS AND USAGE

ZERVIATE™ (cetirizine ophthalmic solution) 0.24% is a histamine-1 (H1) receptor antagonist indicated for treatment of ocular itching associated with allergic conjunctivitis.

DOSAGE AND ADMINISTRATION

Instill one drop of ZERVIATE in each affected eye twice daily (approximately 8 hours apart).

IMPORTANT SAFETY INFORMATION

WARNINGS AND PRECAUTIONS

Contamination of Tip and Solution: As with any eye drop, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle or tip of the single-use container to avoid injury to the eye and to prevent contaminating the tip and solution. Keep the multi-dose bottle closed when not in use. Discard the single-use container after using in each eye.

Contact Lens Wear: Patients should be advised not to wear a contact lens if their eye is red. ZERVIATE should not be instilled while wearing contact lenses. Remove contact lenses prior to instillation of ZERVIATE. The preservative in ZERVIATE, benzalkonium chloride, may be absorbed by soft contact lenses. Lenses may be reinserted 10 minutes following administration of ZERVIATE.

ADVERSE REACTIONS

The most commonly reported adverse reactions occurred in approximately 1%–7% of patients treated with either ZERVIATE or vehicle. These reactions were ocular hyperemia, instillation site pain, and visual acuity reduced.

Please see the Full Prescribing Information.


© 2020 Eyevance Pharmaceuticals LLC. All rights reserved.
ZERVIATE™ and Hydrella™ are trademarks of Eyevance Pharmaceuticals LLC.
*All other trademarks are the property of their respective owners.
ZER-20-WB-55-00